Tenovi and GenieMD Partner to Expand Remote Care and Improve Medication Adherence

Tenovi and GenieMD Partner to Revolutionize Remote Care and Improve Medication Adherence

GenieMD and Tenovi have announced a groundbreaking partnership aimed at expanding access to remote care and improving medication adherence through transformative virtual healthcare solutions. By integrating Tenovi’s FDA-cleared remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) devices with GenieMD’s award-winning virtual care platform, this collaboration delivers a seamless, connected healthcare experience. The partnership launches with the introduction of the Tenovi Pillbox, a device designed to empower individuals managing chronic conditions by providing real-time medication adherence tracking from the comfort of their homes.

Tenovi and GenieMD Partner to Expand Remote Care and Improve Medication Adherence
Addressing the Critical Issue of Medication Non-Adherence

Medication non-adherence is a significant healthcare challenge, particularly for individuals with chronic conditions. Studies indicate that adherence rates average around 50%, well below the 80% threshold needed for optimal treatment effectiveness. Non-adherence can lead to worsening health outcomes, increased hospitalizations, and higher healthcare costs. By offering the Tenovi Pillbox through GenieMD’s virtual care platform, this partnership aims to bridge the gap for Medicare-eligible patients, caregivers, and consumers who may not have access to provider-supported programs.

The Tenovi Pillbox is a smart solution designed to look and function like a traditional 7-day morning and evening pill organizer, offering a familiar and user-friendly experience for patients. Equipped with built-in sensors, the device automatically detects when compartments are opened or refilled. This data is then transmitted in real time to the cloud via the Tenovi Cellular Gateway, allowing healthcare providers and caregivers to monitor adherence and intervene when necessary.

A Synergistic Approach to Virtual Care

GenieMD, recognized as Frost & Sullivan’s 2024 Company of the Year, is a leader in virtual chronic disease management. The company’s AI-powered unified virtual care platform connects patients, caregivers, and providers, facilitating seamless communication and integrated healthcare solutions. By incorporating Tenovi’s advanced RPM and RTM devices into its ecosystem, GenieMD enhances its ability to provide real-time adherence monitoring while also enabling reimbursement for remote monitoring services.

“Our partnership with GenieMD marks a major step in making remote health monitoring more accessible to consumers,” said Jay Lenick, Chief Revenue Officer of Tenovi. “By integrating our FDA-cleared devices with GenieMD’s virtual care platform, we are bridging a crucial gap for individuals who need better tools to manage their health. This collaboration is particularly important for those managing chronic illnesses who require consistent medication adherence and remote monitoring.”

Dr. Soheil Saadat, CEO of GenieMD, echoed this sentiment, emphasizing the importance of empowering individuals in their healthcare journey. “At the heart of our mission is enabling individuals to take control of their health. Our partnership with Tenovi enhances this commitment by delivering premium monitoring devices that integrate effortlessly with our platform, ensuring a seamless and comprehensive health management experience for users.”

The Role of Remote Monitoring in Healthcare Transformation

Remote patient monitoring has emerged as a pivotal component of modern healthcare, particularly in managing chronic diseases such as hypertension, diabetes, and cardiovascular conditions. The ability to collect real-time health data and provide actionable insights to providers helps improve patient outcomes while reducing the burden on traditional healthcare facilities.

Through this partnership, GenieMD’s platform will support a range of Tenovi’s FDA-cleared monitoring devices, including:

  • Tenovi Pillbox – Tracks medication adherence and provides real-time alerts.
  • Blood Pressure Monitors – Helps patients and providers monitor hypertension remotely.
  • Weight Scales – Assists in managing conditions like heart failure and obesity.
  • Pulse Oximeters – Supports monitoring of oxygen levels, particularly important for respiratory conditions.
  • Therapeutic Monitoring Devices – Enhances tracking and compliance with prescribed therapeutic interventions.

The integration of these devices with GenieMD’s AI-driven platform ensures that patient data is efficiently collected, analyzed, and communicated to providers, allowing for timely interventions when necessary. By offering these capabilities within a single ecosystem, the partnership strengthens the accessibility and effectiveness of remote healthcare solutions.

Enhancing Medicare and Consumer Access to Remote Care

One of the primary objectives of this collaboration is to make remote monitoring solutions more widely available to those who need them most. Many Medicare beneficiaries struggle with medication adherence due to cognitive impairments, complex treatment regimens, or lack of caregiver support. By providing real-time monitoring through the Tenovi Pillbox and other RPM/RTM devices, the partnership enables healthcare providers to proactively address adherence challenges, thereby improving patient outcomes and reducing hospitalizations.

For consumers who may not have access to provider-supported remote care programs, the GenieMD and Tenovi collaboration offers a direct-to-consumer solution that allows individuals to take control of their health. The ability to monitor medication adherence remotely and receive timely reminders and alerts empowers patients to stay on track with their treatment plans, ultimately enhancing their overall well-being.

Industry Recognition and Future Prospects

The healthcare industry has increasingly recognized the importance of virtual care and remote monitoring in driving improved health outcomes and reducing costs. GenieMD’s recognition as Frost & Sullivan’s 2024 Company of the Year underscores its commitment to innovation and excellence in the field of virtual healthcare. The partnership with Tenovi further solidifies its position as a leader in chronic disease management and remote monitoring.

Looking ahead, both companies plan to expand their collaborative efforts by integrating additional advanced monitoring solutions and exploring new opportunities to enhance patient engagement and adherence. The future of healthcare is increasingly digital, and partnerships like this pave the way for more efficient, patient-centered care models.

Experience Tenovi and GenieMD’s Innovations at HIMSS 2025

Healthcare professionals and industry leaders will have the opportunity to experience Tenovi’s RPM and RTM devices firsthand at the HIMSS Conference in Chicago from March 3-6, 2025. Attendees can visit Booth #2870 to see the technology in action and engage with leaders from both GenieMD and Tenovi to learn more about their innovative approach to virtual care and medication adherence.

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter